Head-to-head · computed 2026-08-11
Ivim Health vs Willow
Ivim Health: Ivim combines a $75/month membership with tiered medication pricing; its all-in semaglutide figure ($149) is competitive, while tirzepatide lands mid-pack at $278 all-in at the 10 mg basis. Willow: Willow sells patient-specific 503A compounded tirzepatide at a flat $399 a month at every dose, telehealth and shipping included, in 33 states as of mid-2026 reporting.
Tirzepatide
| Ivim Health | Willow | |
|---|---|---|
| All-in maintenance | $278/mo | $399/mo |
| Best plan rate | $278/mo | $399/mo |
| 12-month total | $3,336 | $4,788 |
| Status | Provider-stated · 2026-08-05 | Reported · 2026-08-11 |
The arithmetic
On the figures our desk holds, Ivim Health's $278 a month undercuts Willow's $399 by $121 a month at the 10 mg/wk maintenance basis — $1,452 across a year. Ivim Health's figure is provider-stated (captured 2026-08-05) and Willow's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Ivim Health's tirzepatide ladder runs $278 a month billed monthly. Willow's runs $399 a month billed monthly. On the twelve-month basis Ivim Health's $3,336 beats Willow's $4,788 by $1,452 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Semaglutide
Only Ivim Health offers semaglutide ($149 a month billed monthly); Willow does not, so there is no contest to score.
Where the structures genuinely differ
Willow carries no membership fee against Ivim Health's $75 a month — $900 a year of structural cost before any medication ships, which is why this site prices everything all-in. On dose economics, Willow is dose-flat — the price survives titration — while Ivim Health's pricing can move with the dose, a difference that compounds through a standard escalation schedule and matters most to buyers expecting to reach the higher maintenance doses. On verifiability, Ivim Health names its dispensing pharmacy — which means the fifteen-minute license-and-records check is possible — while Willow's pharmacy is not disclosed on record, the single structural fact this desk weighs heaviest after the FDA's 2026 letters cited exactly that practice.
Structure, side by side
Ivim Health
- Membership$75/mo
- Dose policyTiered by dose on tirzepatide
- CommitmentMonth-to-month
- CancellationCancel anytime
- PharmacyPartner pharmacies
Willow
- MembershipNone
- Dose policyDose-flat per captured reporting: flat $399 at every dose
- CommitmentMonthly
- CancellationPer published terms; confirm at checkout
- PharmacyPatient-specific 503A compounding (pharmacy unnamed on captured materials)
What our desk is watching on each
Ivim Health: Dose-tiered tirzepatide means the advertised start price understates maintenance cost; compare on the maintenance column.
Willow: Reported from a June 15, 2026 comparison table (MenoMellow) — our own capture pending; the flat-at-every-dose structure and 33-state footprint both carry that single-source status until independently confirmed. Pharmacy unnamed on captured materials.
Questions people ask
Is Ivim Health or Willow cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does Ivim Health vs Willow miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do Ivim Health and Willow cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $3,336 at Ivim Health and $4,788 at Willow — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: Ivim Health · Willow. Official sites: Ivim Health ↗ · Willow ↗. Nothing here is medical advice.